Literature DB >> 24740087

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention.

Alexandra Jones1, Ide Cremin2, Fareed Abdullah3, John Idoko4, Peter Cherutich5, Nduku Kilonzo6, Helen Rees7, Timothy Hallett2, Kevin O'Reilly8, Florence Koechlin8, Bernhard Schwartlander9, Barbara de Zalduondo10, Susan Kim1, Jonathan Jay1, Jacqueline Huh1, Peter Piot11, Mark Dybul12.   

Abstract

Large declines in HIV incidence have been reported since 2001, and scientific advances in HIV prevention provide strong hope to reduce incidence further. Now is the time to replace the quest for so-called silver bullets with a public health approach to combination prevention that understands that risk is not evenly distributed and that effective interventions can vary by risk profile. Different countries have different microepidemics, with very different levels of transmission and risk groups, changing over time. Therefore, focus should be on high-transmission geographies, people at highest risk for HIV, and the package of interventions that are most likely to have the largest effect in each different microepidemic. Building on the backbone of behaviour change, condom use, and medical male circumcision, as well as expanded use of antiretroviral drugs for infected people and pre-exposure prophylaxis for uninfected people at high risk of infection, it is now possible to consider the prospect of what would be one of the most remarkable achievements in the history of public health: reduction of HIV transmission from a pandemic to low-level endemicity.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24740087     DOI: 10.1016/S0140-6736(13)62230-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  58 in total

1.  Strengthening HIV surveillance: measurements to track the epidemic in real time.

Authors:  Usangiphile E Buthelezi; Candace L Davidson; Ayesha Bm Kharsany
Journal:  Afr J AIDS Res       Date:  2016-07       Impact factor: 1.300

Review 2.  Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Authors:  Xiao Zang; Emanuel Krebs; Linwei Wang; Brandon D L Marshall; Reuben Granich; Bruce R Schackman; Julio S G Montaner; Bohdan Nosyk
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

Review 3.  Innovative Strategies for Scale up of Effective Combination HIV Prevention Interventions in Sub-Saharan Africa.

Authors:  Kwame Shanaube; Peter Bock
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

4.  Epidemiology at a time for unity.

Authors:  Bryan Lau; Priya Duggal; Stephan Ehrhardt
Journal:  Int J Epidemiol       Date:  2018-10-01       Impact factor: 7.196

5.  AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.

Authors:  Viviane D Lima; Lillian Lourenço; Benita Yip; Robert S Hogg; Peter Phillips; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-03       Impact factor: 12.767

6.  Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis.

Authors:  Xiao Zang; Hawre Jalal; Emanuel Krebs; Ankur Pandya; Haoxuan Zhou; Benjamin Enns; Bohdan Nosyk
Journal:  Value Health       Date:  2020-10-03       Impact factor: 5.725

7.  Short Communication: HIV-DRLink: A Tool for Reporting Linked HIV-1 Drug Resistance Mutations in Large Single-Genome Data Sets Using the Stanford HIV Database.

Authors:  Wei Shao; Valerie F Boltz; Junko Hattori; Michael J Bale; Frank Maldarelli; John M Coffin; Mary F Kearney
Journal:  AIDS Res Hum Retroviruses       Date:  2020-08-27       Impact factor: 2.205

Review 8.  Sustained High HIV Incidence in Young Women in Southern Africa: Social, Behavioral, and Structural Factors and Emerging Intervention Approaches.

Authors:  Abigail Harrison; Christopher J Colvin; Caroline Kuo; Alison Swartz; Mark Lurie
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

9.  Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial.

Authors:  Carolyne A Akello; Katherine E Bunge; Clemensia Nakabiito; Brenda G Mirembe; Mary Glenn Fowler; Anupam Mishra; Jeanne Marrazzo; Zvavahera M Chirenje; Connie Celum; Jennifer E Balkus
Journal:  J Womens Health (Larchmt)       Date:  2017-02-17       Impact factor: 2.681

10.  HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya.

Authors:  Ann E Kurth; Charles M Cleland; Don C Des Jarlais; Helgar Musyoki; John A Lizcano; Nok Chhun; Peter Cherutich
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.